Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 6Sarcoma, Alveolar Soft Part 1Colorectal Neoplasms 1Chondrosarcoma 1Carcinoma, Non-Small-Cell Lung 1

Interventions

belinostat 2Gemcitabine 2Fluorouracil 2venetoclax 1toripalimab 1tazemetostat 1resiquimod 1poly ICLC 1perifosine 1pazopanib 1ivosidenib 1envafolimab 1enasidenib 1durvalumab 1drozitumab 1birinapant 1Quality of Life 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Medicare Part B 1Loperamide 1Leucovorin 1Irinotecan 1Immunotherapy 1Immune Checkpoint Inhibitors 1Imatinib Mesylate 1IPI-926 1IFL protocol 1Fentanyl 1Drug Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Chondrosarcoma × Loperamide × Clear all
NCT00401388 2018-03-07

A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

AEterna Zentaris

Phase 2 Completed
72 enrolled
Sarcoma

Chondrosarcoma, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon âš¡